卡波扎尼布
肝细胞癌
癌症研究
医学
肿瘤进展
内科学
癌症
血管内皮生长因子受体
作者
Caiqi Liu,Jiaqi Shi,Binlin Lin,Meng Zhou,Dan Shan,Jianhua Nie,Yan Wang,Yanqiao Zhang,Peng Han,Tongsen Zheng
标识
DOI:10.2174/1566523222666220825110147
摘要
A novel CDK4/6 inhibitor SHR6390 has shown significant anti-tumor effects. However, its role in hepatocellular carcinoma (HCC) remains unknown.
科研通智能强力驱动
Strongly Powered by AbleSci AI